内皮细胞特异性RTK受体与血管生成
Endothelial cell-specific receptor RTK and angiogenesis
出处
《第三军医大学学报》
CAS
CSCD
北大核心
2005年第4期361-363,共3页
Journal of Third Military Medical University
参考文献19
-
1熊兵,易传勋.血管内皮生长因子其家族与基因治疗[J].中华医学美容杂志,2000,6(6):328-330. 被引量:6
-
2姜自彬,李元.血管内皮生长因子受体的研究进展[J].国外医学(药学分册),2001,28(1):9-13. 被引量:4
-
3方全.血管生成素与肿瘤新生血管生成[J].国外医学(生理病理科学与临床分册),2001,21(5):345-347. 被引量:5
-
4Shewchuk L M, Hassell A M, Ellis B, et al. Structure of the Tie2 RTK domain: self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail[J]. Structure Fold Des, 2000, 8(11): 1105-1113.
-
5Kim I, Kim H G, Moon S O, et al. Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion[J]. Circ Res, 2000, 86(9): 952-959.
-
6Harfouche R, Hassessian H M, Guo Y, et al. Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells[J]. Microvasc Res, 2002, 64(1): 135-147.
-
7Takagi H, Koyama S, Seike H, et al. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization[J]. Invest Ophthalmol Vis Sci, 2003, 44(1): 393-402.
-
8Hanahan D. Signaling vascular morphogenesis and maintenance[J]. Science, 1997, 277(5322): 48-50.
-
9Lobov I B, Brooks P C, Lang R A. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo[J]. Proc Natl Acad Sci U S A, 2002, 99(17): 11205-11210.
-
10Meyer R D, Dayanir V, Majnoun F, et al. The presence of a single tyrosine residue at the carboxyl domain of vascular endothelial growth factor receptor-2/FLK-1 regulates its autophosphorylation and activation of signaling molecules[J]. J Biol Chem, 2002, 277(30): 27081-27087.
二级参考文献45
-
1[1]Ergün S, Kilic N, Fiedler W, et al. Vascular endothelial growth factor and its receptor in normal human testicular tissue[J]. Mol Cell Endocrinol, 1997,131(1):9-20.
-
2[2]Gerber HP, Condorelli F, Park J, et al. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes[J]. J Biol Chem, 1997, 272(38):23659 - 23667.
-
3[3]Suzuki H, Seto K, Shinoda Y, et al. Paracrine upregulation of VEGF receptor mRNA in endothelial cells by hypoxia-exposed Hep G2 cells[J]. Am J Physiol, 1999,276(1): G92 - G97.
-
4[4]Brogi E, Schatteman G, Wu T, et al. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression[J]. J Clin Invest, 1996, 97(2):469-476.
-
5[5]Hata Y, Duh E, Zhang K, et al. Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence [ J ]. J Biol Chem, 1998, 273(30): 19294- 19303.
-
6[6]Giraudo E, Primo L, Audero E, et al. Tumor necrosis factor-α regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells [ J]. J Biol Chem, 1998, 273(34) :22128 - 22135.
-
7[7]Patterson C, Perrella MA, Endege WO, et al. Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-α in cultured human vascular endothelial cells [J]. J Clin Invest, 1996, 98(2) :490 - 496.
-
8[8]de Vries C, Escobedo JA, Ueno H, et al. The fms-like tyrosine kinase,a receptor for vascular endothelial growth factor[J]. Science, 1992, 255(5047) :989- 991.
-
9[9]Terman BI, Dougher-Vermazen M, Carrion ME, et al.Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor[J]. Biochem Biophys Res Commun, 1992, 187(3): 1579 - 1586.
-
10[10]Davis-Smyth T, Chen H, Park J, et al. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade[J]. EMBO J, 1996, 15(18):4919 - 4927.
共引文献12
-
1董光同,高元兴,蒋成榜,付云,池闯.参一胶囊辅治老年食管癌切除后疗效观察[J].浙江中西医结合杂志,2007,17(1):39-40. 被引量:1
-
2李凡,杨为民,叶章群.膀胱癌中缺氧诱导因子-1α的表达和肿瘤血管生成的关系[J].临床泌尿外科杂志,2007,22(4):283-286. 被引量:2
-
3彭解英,王静,邢泉,张睿,张凯.口腔黏膜下纤维化中VEGF mRNA的表达研究[J].临床口腔医学杂志,2007,23(12):715-717. 被引量:3
-
4刘浩,林洪生,花宝金,卢雯平.华蟾素调控VEGF/VEGFR-2信号传导抑制肿瘤血管生成的研究[J].中华中医药学刊,2008,26(11):2489-2491. 被引量:23
-
5马乐,张荣明,李潇,陈峻江.血管生成素-1对移植颗粒脂肪组织存活率的影响[J].辽宁医学院学报,2010,31(1):42-44. 被引量:2
-
6赵忠芳,吕仁荣,霍然,傅洪滨,徐广琪,马少林.普萘洛尔治疗增生期血管瘤患儿血清中血管内皮生长因子及基质金属蛋白酶-9的变化[J].中华整形外科杂志,2011,27(5):359-361. 被引量:12
-
7高崧瀛,刘长松,黄巍.微囊化对转VEGF基因成肌细胞血管内皮生长因子分泌的实验研究[J].黑龙江医学,2012,36(6):417-419. 被引量:2
-
8武彦昭,施惠晶,景尚华,宋军建,赵珍,张兰,单保恩.喉癌组织中VEGF-C及其受体VEGFR-3和D2-40的表达及意义[J].山东医药,2013,53(41):4-7. 被引量:3
-
9赵忠芳,王蕊,马少林.VEGF在增生期血管瘤患儿用普萘洛尔治疗外周血中的表达[J].江苏科技信息,2015,32(19):67-69.
-
10于蕾.中药对肿瘤组织血管生成的影响[J].哈尔滨商业大学学报(自然科学版),2002,18(4):381-384. 被引量:7
-
1弓唯一,董竞成.肿瘤细胞中血管内皮生长因子表达调控的研究进展[J].医学综述,2011,17(4):530-533. 被引量:2
-
2吴筱青,赵洪川.基质金属蛋白酶在结直肠癌组织中的表达及其临床病理意义[J].国际消化病杂志,2011,31(5):258-259.
-
3师怡,林建银.基质金属蛋白酶抑制剂与肿瘤的相关性研究新进展[J].当代医学,2009,15(18):27-28. 被引量:4
-
4陈治,粱发印,张忠明,黄宗海,潘明新.Tie-2受体在大肠癌组织中的表达与血管生成[J].肿瘤,2003,23(3):217-219. 被引量:1
-
5李庆研,党延玲,刘彦婷,耿松梅.微静脉血管瘤[J].临床皮肤科杂志,2015,44(10):601-602.
-
6马东来,李峰,方凯.微静脉性血管瘤[J].临床皮肤科杂志,2009,38(10):637-638. 被引量:3
-
7张建国,朱贤立,姜晓兵,周伟.Tie-2受体在人脑胶质瘤中的表达及意义[J].中国临床神经外科杂志,2004,9(5):345-347. 被引量:1
-
8茹义松.白血病干细胞靶向治疗研究进展[J].中国实用医药,2012,7(28):242-243. 被引量:1
-
9王文鹏,黄光磊,薛英威.胃腺癌脉管浸润的临床病理特征及预后分析[J].肿瘤学杂志,2015,21(12):988-992. 被引量:2
-
10江波,赵金奇,@张灿珍,张灿珍.VEGF及其受体与肺癌关系的研究进展[J].临床肿瘤学杂志,2006,11(1):72-74. 被引量:11